Poongjeon Pharmacy CO.,LTD. (KOSDAQ:298060)
South Korea
· Delayed Price · Currency is KRW 4,635.00
+95.00 (2.09%)
At close: Apr 22, 2026
Poongjeon Pharmacy CO.,LTD. Company Description
POONGJEON PHARMACY CO.,LTD. operates as a stem cell therapy company in South Korea. It develops SCM-AGH, a treatment for moderate to severe acute pancreatitis and moderate to severe atopic dermatitis, as well as chronic graft versus host disease; and Iroro Deerscalp, a toothbrush cosmetic for hair loss relief.
The company was formerly known as SCM Lifescience Co., Ltd. and change its name to POONGJEON PHARMACY CO.,LTD.
in April 2026. The company was incorporated in 2014 and is headquartered in Incheon, South Korea.
Poongjeon Pharmacy CO.,LTD.
| Country | South Korea |
| Founded | 2014 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Byeong-gwan Son |
Contact Details
Address: 7-7, Gaetbeol-ro 145beon-gil Incheon, 21999 South Korea | |
| Phone | 82 3 2881 3600 |
| Website | scmlifescience.co.kr |
Stock Details
| Ticker Symbol | 298060 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Byeong-gwan Son | Chief Executive Officer |
| Sukwoo Jeffrey Oh | Chief Operating Officer |